Crispr Therapeutics shares tumble after significant earnings miss
Cadre Holdings, Inc. (CDRE) stock has touched a 52-week low, dipping to $29.17 amidst market fluctuations. According to InvestingPro data, the company maintains strong financial health with a current ratio of 3.48, indicating robust liquidity. This price level reflects a significant downturn from the company’s performance over the past year, with Cadre Holdings experiencing an 18.51% decline in its stock value year-over-year. Despite the decline, the company has demonstrated strong revenue growth of 17.62% in the last twelve months, and analysts maintain price targets ranging from $40 to $48. Investors are closely monitoring the company’s trajectory as it navigates through the challenges that have led to this low point, considering both market trends and the firm’s strategic responses. InvestingPro subscribers can access 7 additional key insights about CDRE, including detailed profitability metrics and growth forecasts in the comprehensive Pro Research Report.
In other recent news, Cadre Holdings reported its fourth-quarter 2024 earnings, showcasing mixed results. The company missed the expected earnings per share (EPS) of $0.49, posting $0.32 instead, but exceeded revenue forecasts with a record $175.98 million, surpassing the anticipated $162.81 million. Despite the EPS miss, the strong revenue performance reflects robust sales and strategic market positioning. Additionally, Cadre Holdings announced a strategic acquisition of the engineering division from Cars Group, expanding its footprint in the nuclear safety sector. This acquisition is expected to enhance Cadre’s capabilities in automation, robotics, and nuclear medicine. Analyst firms have noted the company’s proactive approach to mitigating tariff impacts, which could potentially affect profitability. Furthermore, Cadre Holdings has projected net sales between $572 million and $610 million for 2025, with adjusted EBITDA expected to range from $105 million to $115 million. These developments indicate Cadre Holdings’ strategic focus on growth through mergers and acquisitions, along with maintaining a strong market position in key sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.